Financial results - ANGIOFLUXMED S.R.L.

Financial Summary - Angiofluxmed S.r.l.
Unique identification code: 41255877
Registration number: J2019000505196
Nace: 8622
Sales - Ron
82.262
Net Profit - Ron
38.177
Employees
2
Open Account
Company Angiofluxmed S.r.l. with Fiscal Code 41255877 recorded a turnover of 2024 of 82.262, with a net profit of 38.177 and having an average number of employees of 2. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Angiofluxmed S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 931 7.352 11.984 10.174 67.867 82.262
Total Income - EUR - - - - 931 7.352 11.984 10.187 67.867 82.263
Total Expenses - EUR - - - - 867 1.720 848 2.073 26.153 41.988
Gross Profit/Loss - EUR - - - - 65 5.632 11.136 8.114 41.714 40.275
Net Profit/Loss - EUR - - - - 37 5.474 10.960 7.871 41.070 38.177
Employees - - - - 0 0 0 1 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 21.9%, from 67.867 euro in the year 2023, to 82.262 euro in 2024. The Net Profit decreased by -2.663 euro, from 41.070 euro in 2023, to 38.177 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Angiofluxmed S.r.l.

Rating financiar

Financial Rating -
ANGIOFLUXMED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Angiofluxmed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Angiofluxmed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Angiofluxmed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Angiofluxmed S.r.l. - CUI 41255877

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 673 473 396 7.859 24.332 30.695
Current Assets - - - - 1.085 5.079 11.843 12.408 23.443 19.320
Inventories - - - - 307 0 0 331 0 982
Receivables - - - - 0 253 437 836 3.750 0
Cash - - - - 778 4.826 11.406 11.241 19.694 18.338
Shareholders Funds - - - - 79 5.552 12.143 20.052 43.877 46.247
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 1.678 0 96 215 3.911 3.877
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 19.320 euro in 2024 which includes Inventories of 982 euro, Receivables of 0 euro and cash availability of 18.338 euro.
The company's Equity was valued at 46.247 euro, while total Liabilities amounted to 3.877 euro. Equity increased by 2.615 euro, from 43.877 euro in 2023, to 46.247 in 2024.

Risk Reports Prices

Reviews - Angiofluxmed S.r.l.

Comments - Angiofluxmed S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.